The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Market Size Of The Infusion Therapy Devices Market Expected To Scale Between 2026 And 2030?
The infusion therapy devices market size has experienced significant expansion in recent years. It is anticipated to grow from $13.33 billion in 2025 to $14.74 billion in 2026, at a compound annual growth rate (CAGR) of 10.5%. The historical growth of this market can be attributed to factors such as the increasing prevalence of chronic diseases, a rise in hospital admissions necessitating infusion therapy, the expansion of oncology and diabetes treatments, the growing adoption of intravenous drug delivery, and enhanced availability of infusion devices.
The infusion therapy devices market is anticipated to experience significant expansion over the next few years. It is projected to achieve a value of $21.82 billion by 2030, growing at a compound annual growth rate (CAGR) of 10.3%. This projected growth is driven by factors such as the increasing demand for home healthcare services, the rising adoption of connected medical devices, the expansion of personalized medicine delivery, a heightened focus on reducing medication errors, and growing investments in smart hospital infrastructure. Prominent trends for the forecast period include the increasing adoption of smart infusion pumps, a rising demand for portable and ambulatory infusion devices, the growing integration of dose error reduction systems, the expansion of home-based infusion therapy, and an enhanced focus on patient safety and monitoring.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20849&type=smp
What Factors Are Contributing To The Growth Of The Infusion Therapy Devices Market?
The increasing prevalence of chronic diseases is anticipated to propel the growth of the infusion therapy devices market in the future. Chronic diseases are defined as long-lasting health conditions persisting for a year or more, necessitating ongoing medical attention or limiting daily activities. This rise in chronic illness prevalence can be attributed to poor lifestyle choices, sedentary habits, unhealthy diets, environmental influences, and an increase in risk factors such as obesity, smoking, and stress. Infusion therapy devices effectively manage these conditions by ensuring the precise and controlled delivery of medications and fluids directly into the bloodstream, providing consistent and effective treatment for ailments like diabetes, autoimmune disorders, and cancer. This leads to improved patient outcomes, greater convenience, and a reduced need for frequent hospital visits. For instance, in January 2023, the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, projected a 99.5% surge in the number of individuals aged 50 years and above with at least one chronic illness by 2050, increasing from 71.522 million in 2020 to 142.66 million. Consequently, the rising prevalence of chronic diseases is a significant driver for the growth of the infusion therapy devices market.
Which Segment Types Are Examined In The Infusion Therapy Devices Market Segment Study?
The infusion therapy devices market covered in this report is segmented –
1) By Product: Infusion Pumps, Intravenous (Iv) Sets, Cannulas, Needleless Connectors
2) By Mobility: Portable Infusion Pumps, Stationary Pumps
3) By Application: Oncology, Diabetes, Pain Management, Other Applications
4) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Homecare, Other End-Users
Subsegments:
1) By Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps, Insulin Infusion Pumps
2) By Intravenous (IV) Sets: Standard IV Sets, Extension IV Sets, IV Administration Sets with Filters
3) By Cannulas: Peripheral Intravenous (PIV) Cannulas, Central Venous Cannulas, Butterfly Cannulas
4) By Needleless Connectors: Positive Pressure Needleless Connectors, Neutral Pressure Needleless Connectors, Negative Pressure Needleless Connectors
What Trends Are Shaping The Future Of The Infusion Therapy Devices Market?
Leading companies in the infusion therapy devices market are concentrating on developing innovative solutions, such as pressure-enabled drug delivery (PEDD) technology, to enhance the treatment of liver and pancreatic tumors. Pressure-enabled drug delivery (PEDD) refers to a drug delivery method that utilizes pressure to improve the infusion of therapeutic agents into tissues or organs, especially in areas where conventional approaches may encounter difficulties. For example, in November 2024, TriSalus Life Sciences, a US-based medical technology company, launched the TriNav LV Infusion System and TriGuide Guiding Catheters. This expanded its pressure-enabled drug delivery (PEDD) portfolio to optimize therapeutic delivery, enhancing treatment options and potentially improving patient outcomes. The TriNav LV Infusion System offers unique features, such as compatibility with larger blood vessels (3.5 to 5.0 mm), thereby extending the use of TriSalus’ Pressure-Enabled Drug Delivery (PEDD) technology to a broader patient population. This launch expands PEDD device compatibility from 1.5 mm to 5.0 mm vessels, providing interventional radiologists with more treatment options. TriGuide Guiding Catheters incorporate a larger inner diameter, a lubricious lining, and a reverse curve design for easier femoral access and improved procedural efficiency. Early users have reported a 97% satisfaction rate, emphasizing the system’s effectiveness and ease of use in oncology treatments.
Which Players Are Part Of The Competitive Landscape Of The Infusion Therapy Devices Market?
Major companies operating in the infusion therapy devices market are Roche Holding AG, Fresenius Kabi AG, Medtronic plc, Medline Industries Inc., Baxter International Inc., Terumo Corporation, Mindray Medical International Limited, Nipro Corporation, ICU Medical Inc., Cook Medical, LivaNova PLC, Vygon S.A., AngioDynamics Inc., B. Braun Melsungen AG, Moog Medical Devices Group, Kangaroo, Vantage Medical Technologies, Alaris Medical Systems Inc., Smiths Medical, Teleflex Incorporated
Get The Full Infusion Therapy Devices Market Report:
https://www.thebusinessresearchcompany.com/report/infusion-therapy-devices-global-market-report
Which Region Leads The Infusion Therapy Devices Market In Overall Market Size?
North America was the largest region in the infusion therapy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infusion therapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Infusion Therapy Devices Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=20849&type=smp
Browse Through More Reports Similar to the Global Infusion Therapy Devices Market 2026, By The Business Research Company
Cigarette Filters Market Report 2026
https://www.thebusinessresearchcompany.com/report/cigarette-filters-global-market-report
Bag Filter Market Report 2026
https://www.thebusinessresearchcompany.com/report/bag-filter-global-market-report
Filters Market Report 2026
https://www.thebusinessresearchcompany.com/report/filters-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model